Ji Eun Lee

This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ji Eun Lee. Retrieved from https://idiyas.com/inventor/ji-eun-lee-kpbgsngc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ji Eun Lee: Innovator in Long-Acting Drug Conjugates

Introduction

Ji Eun Lee is a notable inventor recognized for his contributions to the pharmaceutical industry. He is currently associated with Hanmi Pharmaceutical Co., Ltd., where he focuses on innovative drug delivery systems. His work aims to enhance the efficacy and longevity of therapeutic agents.

Latest Patents

Ji Eun Lee holds a patent for a "Novel Method for Preparing Long-Acting Drug Conjugate Through Preparation of Intermediate." This innovative approach is designed to improve the effectiveness of drug formulations, making them more beneficial for patients.

Career Highlights

Throughout his career, Ji Eun Lee has demonstrated a commitment to advancing pharmaceutical technologies. His work has led to significant improvements in drug delivery methods, which are crucial for patient care and treatment outcomes.

Collaborations

Ji Eun Lee has collaborated with talented colleagues, including Cheongbyeol Shin and Jin Sung Kim. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Ji Eun Lee's contributions to the field of pharmaceuticals, particularly in long-acting drug conjugates, highlight his role as an innovative inventor. His work continues to impact the industry positively, paving the way for future advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…